Early Phase I data shows promise for mRNA cancer immunotherapy in advanced solid cancers

Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers.

Biotest Supervisory Board extends Management Board contract of Dr Jörg Schüttrumpf by 5 years – Biotech Investments

EQS-News: Biotest AG / Key word(s): Personnel Biotest AG: Biotest Supervisory Board extends Management Board contract of Dr Jörg Schüttrumpf by 5 years 04.09.2023 /

September 5, 2023

A popular breast cancer genomic test underestimates risks for Black women

When a woman first learns she has breast cancer, her mind immediately floods with “what now?” questions as she grapples with how this disease will

September 19, 2023

Novel Goalpost for PCI Excellence Is Borrowed From the Surgeons

Researchers made a case for failure to rescue (FTR) as a potential quality metric in percutaneous coronary intervention (PCI), using records from a large nationwide

July 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.